Skip to main content

Ben Bates

Postdoctoral Fellow in Cancer Pharmacoepidemiology

Ben Bates (M.D., University of Mississippi Medical Center; Internal Medicine Residency, Rutgers-RWJMS) is a board-certified physician in internal medicine and presently a post-doctoral fellow in cancer pharmacoepidemiology. His research focuses on understanding the real-world use, effectiveness and adverse outcomes of treatments. The majority of his research involves the evaluation of treatments among patients with cancer,

Matthew Beier

Medical Student

About Matt Beier is a medical student at Rutgers, Robert Wood Johnson Medical School working under the guidance of Dr. Daniel Horton.  He previously earned a B.S. in Chemical Engineering from Oklahoma State University and an M.F.E. from UC Berkeley. Matt spent close to a decade working on Wall Street and in Silicon Valley before

Daniel Dudman

Post-Doctoral Fellow

About Daniel Dudman (Butler University, 2019) is a post-doctoral fellow in Quantitative Safety & Epidemiology at the Rutgers Institute for Pharmaceutical Industry Fellowships and Novartis. Daniel has a background in big data analysis, which he uses to conduct his epidemiology research.  He is also pursuing a certificate in pharmacoepidemiology at the Rutgers School of Public

Mackenzie Henderson

Post-Doctoral Fellow, Pharmacoepidemiology

About Mackenzie Henderson (PharmD, Rutgers Ernest Mario School of Pharmacy, 2019) is a post-doctoral fellow in pharmacoepidemiology at the Rutgers Institute for Pharmaceutical Industry Fellowships and Daiichi Sankyo, Inc., mainly focused on oncology research. Additionally, she is adjunct faculty at the Rutgers Ernest Mario School of Pharmacy and is currently working toward a certificate in

Julia Liaw

Research Assistant

About Julia Liaw (PharmD Candidate 2023 Rutgers, The State University of New Jersey – New Brunswick, NJ) has been a junior research assistant at PETS for over a year. At the Center, Julia performs data management, data analyses for methodological and pharmacoepidemiological studies including studies on whether Angiotensin II Receptors Blockers (ARBs) generics tainted with Nitrosamines (NDMA)

Eric Wang

Post-doctoral Pharmacoepidemiology Fellow

About Eric Wang, PharmD is a new graduate from the University of Missouri-Kansas City School of Pharmacy. He is currently working as a pharmacoepidemiology fellow at Daiichi-Sankyo Inc.

Tianyi Yang

Research Assistant

About Tianyi (Hilary) Yang is an ungraduated student in Rutgers University, majoring in Public Health and Biological Science. Under the instructions from PETS professionals, she supports ongoing research studies by conducting data entry, literature reviews, document review, simple analysis, and overall general administrative project support as needed. She is interested in pursuing a Master of